Journal
PLOS ONE
Volume 8, Issue 8, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0072138
Keywords
-
Categories
Funding
- Fonds de la Recherche en Sante du Quebec (FRSQ)
- Canadian Institutes of Health Research
Ask authors/readers for more resources
S100A8 and S100A9 are cytoplasmic proteins expressed by phagocytes. High concentrations of these proteins have been correlated with various inflammatory conditions, including autoimmune diseases such as rheumatoid arthritis and Crohn's disease, as well as autoinflammatory diseases. In the present study, we examined the effects of S100A8 and S100A9 on the secretion of cytokines and chemokines from PBMCs. S100A8 and S100A9 induced the secretion of cytokines such as IL-6, IL-8, and IL-1 beta. This secretion was associated with the activation and translocation of the transcription factor NF-kappa B. Inhibition studies using antisense RNA and the pharmacological agent BAY-117082 confirmed the involvement of NF-kappa B in IL-6, IL-8, and IL-1 beta secretion. S100A8- and S100A9-mediated activation of NF-kappa B, the NLR family, pyrin domain-containing 3 (NLRP3) protein, and pro-IL-1 beta expression was dependent on the generation of reactive oxygen species. This effect was synergistically enhanced by ATP, a known inflammasome activator. These results suggest that S100A8 and S100A9 enhance the inflammatory response by inducing cytokine secretion of PBMCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available